Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pharming (PHAR) Other Non Operating Income (2019 - 2025)

Historic Other Non Operating Income for Pharming (PHAR) over the last 7 years, with Q3 2025 value amounting to -$119000.0.

  • Pharming's Other Non Operating Income fell 66666.67% to -$119000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 7371.84%. This contributed to the annual value of $5.0 million for FY2024, which is 63655.91% up from last year.
  • According to the latest figures from Q3 2025, Pharming's Other Non Operating Income is -$119000.0, which was down 66666.67% from $1.3 million recorded in Q2 2025.
  • Over the past 5 years, Pharming's Other Non Operating Income peaked at $5.1 million during Q2 2024, and registered a low of -$8.2 million during Q4 2021.
  • For the 5-year period, Pharming's Other Non Operating Income averaged around -$169267.6, with its median value being $21000.0 (2024).
  • Over the last 5 years, Pharming's Other Non Operating Income had its largest YoY gain of 269331.19% in 2022, and its largest YoY loss of 3966367.2% in 2022.
  • Over the past 5 years, Pharming's Other Non Operating Income (Quarter) stood at -$8.2 million in 2021, then soared by 85.29% to -$1.2 million in 2022, then grew by 22.5% to -$930000.0 in 2023, then soared by 81.83% to -$169000.0 in 2024, then grew by 29.59% to -$119000.0 in 2025.
  • Its last three reported values are -$119000.0 in Q3 2025, $1.3 million for Q2 2025, and $604000.0 during Q1 2025.